Dallas, TX, United States of America

Victor F Ghetie



Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Victor F Ghetie: Innovator in Vaccine Development

Introduction

Victor F Ghetie is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of vaccine development. With a total of 7 patents to his name, Ghetie's work focuses on creating innovative solutions to combat the effects of toxic proteins.

Latest Patents

Among his latest patents, Ghetie has developed methods for producing toxoid vaccines, specifically targeting ricin A chain mutants that lack enzymatic activity. This invention aims to provide vaccines that reduce the risk of vascular leak syndrome (VLS) and catalytic toxicity associated with various proteinaceous toxins. Additionally, he has created methods for modifying the toxic effects of proteinaceous compounds, producing immunotoxins and cytokines that minimize the promotion of VLS. His work also includes the development of peptides that inhibit the induction of VLS by these compounds.

Career Highlights

Ghetie is affiliated with the University of Texas System, where he continues to advance research in immunology and vaccine technology. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and treatment of toxic protein exposure.

Collaborations

Ghetie has collaborated with notable colleagues, including Ellen S Vitetta and Joan Elizabeth Smallshaw, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Victor F Ghetie's work exemplifies the intersection of innovation and public health, as he strives to develop safer and more effective vaccines. His contributions are vital in the ongoing battle against toxic protein threats.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…